{"id":339448,"date":"2025-06-05T10:00:07","date_gmt":"2025-06-05T04:30:07","guid":{"rendered":"https:\/\/forumias.com\/blog\/?page_id=339448"},"modified":"2025-06-05T10:00:07","modified_gmt":"2025-06-05T04:30:07","slug":"answered-the-contentious-approval-of-gm-mustard-dmh-11-highlights-indias-challenge-in-balancing-health-concerns-with-potential-economic-and-nutritional-benefits-analyze-the-governance-and-polic","status":"publish","type":"page","link":"https:\/\/forumias.com\/blog\/answered-the-contentious-approval-of-gm-mustard-dmh-11-highlights-indias-challenge-in-balancing-health-concerns-with-potential-economic-and-nutritional-benefits-analyze-the-governance-and-polic\/","title":{"rendered":"[Answered] The contentious approval of GM mustard (DMH-11) highlights India&#8217;s challenge in balancing health concerns with potential economic and nutritional benefits. Analyze the governance and policy dilemmas in regulating genetically modified crops, ensuring scientific rigor, public safety, and agricultural sustainability."},"content":{"rendered":"<h2><strong>Introduction<\/strong><\/h2>\n<p>The controversy over India\u2019s indigenously developed genetically modified (GM) mustard \u2014 Dhara Mustard Hybrid-11 (DMH-11) \u2014 reflects the complex intersection of science, health, economy, and governance. While DMH-11 promises higher yields and lower erucic acid content in mustard oil, concerns persist over its biosafety, ecological impact, and regulatory transparency. India, being a signatory to the Cartagena Protocol on Biosafety, must balance scientific advancement with public confidence, environmental sustainability, and constitutional accountability.<\/p>\n<h2><strong>Scientific and Economic Significance of DMH-11<\/strong><\/h2>\n<ol>\n<li><strong>Nutritional and Health Benefits<\/strong>: Traditional mustard oil in India contains 40-54% erucic acid, well above the &lt;5% global safety threshold. High levels are linked to cardiac and liver issues in animal studies. DMH-11 reduces erucic acid to 30-35%, aligning it closer to international standards and potentially improving public health.<\/li>\n<li><strong>Economic Advantage<\/strong>: India is the <strong>world\u2019s largest importer of edible oils<\/strong>, with an import bill exceeding $20 billion (NITI Aayog, 2024). A high-yield, low-erucic acid mustard could reduce this burden. Higher domestic yields (by 25-30%) also align with the government\u2019s goal of doubling farmers\u2019 income and achieving <strong>oilseed self-reliance (Atmanirbharata)<\/strong>.<\/li>\n<li><strong>Agronomic Merits<\/strong>: DMH-11 uses the barnase-barstar gene system for hybrid vigour, enabling higher productivity. Trials by the Indian Council of Agricultural Research (ICAR) suggest yield gains without adverse agro-ecological impact.<\/li>\n<\/ol>\n<h2><strong>Governance and Regulatory Dilemmas<\/strong><\/h2>\n<ol>\n<li><strong>Regulatory Fragmentation<\/strong>: India&#8217;s biotech governance is overseen by multiple bodies \u2014 GEAC (Genetic Engineering Appraisal Committee), FSSAI, and the Environment Ministry \u2014 leading to <strong>overlaps, delays, and lack of coordination<\/strong>. The Supreme Court (2024) withheld environmental release, citing insufficient health impact assessments, exposing regulatory gaps.<\/li>\n<li><strong>Lack of Transparency and Public Participation<\/strong>: Critics allege non-disclosure of full biosafety data, limited stakeholder consultations, and inadequate <strong>risk communication<\/strong>, fueling distrust. Civil society and farmer groups demand <strong>independent, peer-reviewed evidence<\/strong>, not solely developer-led trials.<\/li>\n<li><strong>Policy Inconsistency<\/strong>: While Bt cotton is widely cultivated (95% of India\u2019s cotton area), GM food crops like brinjal and mustard face moratoriums, reflecting <strong>incoherence in biotech policy<\/strong>. The <strong>absence of a comprehensive GM crop policy or biosafety law<\/strong> further complicates approvals and oversight.<\/li>\n<\/ol>\n<h2><strong>Balancing Risks and Sustainability<\/strong><\/h2>\n<ol>\n<li><strong>Scientific Rigor<\/strong>: Robust, multi-location, long-term field trials with transparent data sharing must be institutionalized. An autonomous biosafety authority, as recommended by the <strong>Parliamentary Standing Committee (2017)<\/strong>, could ensure credibility and insulation from political influence.<\/li>\n<li><strong>Environmental Concerns<\/strong>: Cross-pollination risks to wild relatives of mustard, impact on pollinators (especially bees), and herbicide tolerance traits demand <strong>ecological risk management<\/strong>.<\/li>\n<li><strong>Alternative Approaches<\/strong>: Conventional breeding, CRISPR-based gene editing, and marker-assisted selection (non-transgenic) can offer safer and publicly acceptable alternatives.<\/li>\n<\/ol>\n<h2><strong>Conclusion<\/strong><\/h2>\n<p>The DMH-11 episode epitomizes the challenges of integrating science with policy in a democratic, diverse society. India needs a <strong>coherent, transparent, and evidence-based regulatory framework<\/strong> that encourages innovation while safeguarding public health, ecology, and farmers\u2019 rights. Trust-building through scientific integrity and participatory governance is crucial for the sustainable adoption of GM technology.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Introduction The controversy over India\u2019s indigenously developed genetically modified (GM) mustard \u2014 Dhara Mustard Hybrid-11 (DMH-11) \u2014 reflects the complex intersection of science, health, economy, and governance. While DMH-11 promises higher yields and lower erucic acid content in mustard oil, concerns persist over its biosafety, ecological impact, and regulatory transparency. India, being a signatory to&hellip; <a class=\"more-link\" href=\"https:\/\/forumias.com\/blog\/answered-the-contentious-approval-of-gm-mustard-dmh-11-highlights-indias-challenge-in-balancing-health-concerns-with-potential-economic-and-nutritional-benefits-analyze-the-governance-and-polic\/\">Continue reading <span class=\"screen-reader-text\">[Answered] The contentious approval of GM mustard (DMH-11) highlights India&#8217;s challenge in balancing health concerns with potential economic and nutritional benefits. Analyze the governance and policy dilemmas in regulating genetically modified crops, ensuring scientific rigor, public safety, and agricultural sustainability.<\/span><\/a><\/p>\n","protected":false},"author":10320,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"jetpack_post_was_ever_published":false,"footnotes":""},"class_list":["post-339448","page","type-page","status-publish","hentry","entry"],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/pages\/339448","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/users\/10320"}],"replies":[{"embeddable":true,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/comments?post=339448"}],"version-history":[{"count":0,"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/pages\/339448\/revisions"}],"wp:attachment":[{"href":"https:\/\/forumias.com\/blog\/wp-json\/wp\/v2\/media?parent=339448"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}